Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$NTLA stock is up 20% today. Here's what we see in our data.

None

$NTLA stock has now risen 20% today, according to our price data from Polygon. There has been approximately $39,779,573 of trading volume.

It has been the 419th most-searched ticker on Quiver Quantitative over the last day, out of 10,591 total tickers searched.

Here is what we see in our data on $NTLA (you can track the company live on Quiver's $NTLA stock page):

$NTLA Insider Trading Activity

NTLA Insider Trades

$NTLA insiders have traded $NTLA stock on the open market 14 times in the past 6 months. Of those trades, 2 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $NTLA stock by insiders over the last 6 months:

  • FRED E COHEN purchased 150,000 shares for an estimated $1,402,500
  • JOHN M LEONARD (President and CEO) has made 0 purchases and 4 sales selling 122,292 shares for an estimated $1,150,869.
  • WILLIAM J CHASE purchased 100,000 shares for an estimated $1,002,999
  • DAVID LEBWOHL (EVP, Chief Medical Officer) sold 11,903 shares for an estimated $109,626
  • JAMES BASTA (EVP, General Counsel) sold 10,397 shares for an estimated $95,756
  • ELIANA CLARK (EVP, Chief Technical Officer) sold 9,515 shares for an estimated $87,633
  • BIRGIT C SCHULTES (EVP, Chief Scientific Officer) has made 0 purchases and 2 sales selling 8,539 shares for an estimated $78,897.
  • MICHAEL P DUBE (VP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 4,860 shares for an estimated $60,046.
  • EDWARD J III DULAC (EVP, Chief Financial Officer) sold 6,379 shares for an estimated $58,750

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NTLA Hedge Fund Activity

We have seen 150 institutional investors add shares of $NTLA stock to their portfolio, and 121 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$NTLA Analyst Ratings

Wall Street analysts have issued reports on $NTLA in the last several months. We have seen 7 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Truist Securities issued a "Buy" rating on 11/10/2025
  • HC Wainwright & Co. issued a "Buy" rating on 11/10/2025
  • Citizens issued a "Market Outperform" rating on 11/07/2025
  • Chardan Capital issued a "Buy" rating on 11/07/2025
  • Barclays issued a "Overweight" rating on 11/07/2025
  • JP Morgan issued a "Underweight" rating on 11/07/2025
  • JMP Securities issued a "Market Outperform" rating on 10/28/2025

To track analyst ratings and price targets for $NTLA, check out Quiver Quantitative's $NTLA forecast page.

$NTLA Price Targets

Multiple analysts have issued price targets for $NTLA recently. We have seen 13 analysts offer price targets for $NTLA in the last 6 months, with a median target of $14.0.

Here are some recent targets:

  • Jonathan Miller from Evercore ISI Group set a target price of $8.0 on 11/11/2025
  • Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $15.0 on 11/10/2025
  • Joon Lee from Truist Securities set a target price of $14.0 on 11/10/2025
  • Gena Wang from Barclays set a target price of $14.0 on 11/07/2025
  • Yanan Zhu from Wells Fargo set a target price of $12.0 on 11/07/2025
  • Geulah Livshits from Chardan Capital set a target price of $26.0 on 11/07/2025
  • David Nierengarten from Wedbush set a target price of $7.0 on 11/07/2025

You can track data on $NTLA on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles